ARCHIVES

Interferon “Hysteria” Prompts ASCO To Warn Against Expecting Immediate Benefits

This article is from The Cancer Letter archive.

Vol. 06 No. 25 | June 20, 1980

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

August 4, 1995

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

October 20, 2006

FDA Adopts Final Diagnostics X-Ray Rule Amendment

September 9, 1977

Cancer Control RFA Announcements

March 9, 1979

DCT Board Okays $3 Million In New Programs, $8 Million In Recompetitions

October 24, 1980

Natcher Subcommittee Open Door To justification for Increasing Cancer Program 1982 Appropriation

April 3, 1981